CD8A and secondary progressive multiple sclerosis: Accordingly, these distinct phenotypes of CD8 + T cell in SPMS patients not only prompted us to further think about its diagnostic probabilities to improve classification rate, but would also be a potentially therapeutic target for preventing disease progression.